Oleg Nodelman
@Ecor1 Capital, Llc
Latest period2024 - Q3ReportedManaged Assets$2.922BTotal holdings63
Assets growth rate-10.62%Assets growth rate (2-Q avg)-13.97%Continuous growth in asset value0 quarters
Portfolio positions
This chart displays the top 10 holdings in Ecor1 Capital, Llc's 2024 - Q3 portfolio, based on their 13F SEC filing, out of a total of 63 positions.
Assets under management
The assets under management (AUM) of Ecor1 Capital, Llc over the past 10 years (40 quarters) show continuous growth in total asset value over the last 0 quarters. As of the latest 13F SEC filing for 2024 - Q3, they manage 2.922B in assets, with a quarterly growth rate of -10.62% and a 2-quarter average growth rate of -13.97%. The portfolio is managed by Oleg Nodelman, and others.
Portfolio holdings
Investment | Portfolio % | Reported Value | Recent Activity |
---|---|---|---|
SRPTSarepta Therapeutics Inc
| 0% | $222.357M 1.407M shares@ $158.0 avg price | Exited |
MORFMorphic Hldg Inc
| 0% | $169.769M 4.983M shares@ $34.07 avg price | Exited |
ACADAcadia Pharmaceuticals Inc
| 0% | $21.88M 1.346M shares@ $16.26 avg price | Exited |
RCKTRocket Pharmaceuticals Inc
| 0% | $10.946M 508,393 shares@ $21.53 avg price | Exited |
HOOKHookipa Pharma Inc
| 0% | $3.384M 5.717M shares@ $0.6 avg price | Exited |
ALGSAligos Therapeutics Inc
| 0% | $2.236M 6.389M shares@ $0.36 avg price | Exited |